George W. LeMaitre, Chairman and CEO at LEMAITRE VASCULAR INC (LMAT), sold 100,000 shares at $93.51 ($9.4M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Scheduled sale ($9.4M) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LMAT | SELL | 2025-05-20 | $16.3M | — | Filing → |
| LMAT | SELL | 2024-07-18 | $9.9M | — | Filing → |
| LMAT | SELL | 2024-07-16 | $6.9M | — | Filing → |